Autism spectrum disorder is being identified more often around the world, and the “rise” looks different depending on where and how data is collected. On this page, we connect changes in criteria, earlier screening, and diagnostic substitution to shifts in measured prevalence. We also compare surveillance snapshots across countries and explore how diagnosis timing and age of identification can change apparent trends.
Key Takeaways
- DSM-IV to DSM-5 broadened criteria, contributing to 60% of rise per studies
- Diagnostic substitution: 48% of previous MR/ID cases now ASD (1994-2007 California)
- Increased awareness led to 25% rise in UK diagnoses 2000-2010
- UK NHS data 2023: ASD prevalence in children estimated at 1-2%, up from 0.5% in 2000s
- Australia 2022 report: 1 in 70 children (1.43%) diagnosed with ASD, double from 2012's 1 in 150
- South Korea 2011 study: 2.64% (1 in 38) ASD prevalence in community sample
- US ASD prevalence increased from 1 in 150 (2000) to 1 in 36 (2023), 322% rise
- From 2000 to 2010, ASD rates rose 78% per CDC surveillance
- 1990s US estimates ~1 in 2,000 to 1 in 500 by early 2000s
- In 2023, the CDC reported that 1 in 36 children aged 8 years (2.78%) were identified with ASD in the US, up from 1 in 44 (2.27%) in 2018
- CDC ADDM Network 2023 data shows ASD prevalence among 8-year-olds reached 1 in 36 (27.6 per 1,000), a 278% increase since 2000's 1 in 150 (6.7 per 1,000)
- US prevalence of ASD in children aged 8 years was 1 in 54 (18.5 per 1,000) in 2016, rising to 1 in 36 by 2020 data
- California DDS data shows ASD caseload rose from 6,000 in 1999 to over 100,000 by 2020
- New Jersey 2020 ADDM site: 1 in 32 (3.13%) 8-year-olds with ASD, highest monitored rate
- Missouri ADDM 2020: 1 in 37 (2.70%) prevalence among 8-year-olds
ASD diagnoses have surged worldwide, with broader criteria and earlier detection driving major increases.
Related reading
01 · Category
Diagnostic And Awareness Factors20 stats
01
DSM-IV to DSM-5 broadened criteria, contributing to 60% of rise per studies
02
Diagnostic substitution: 48% of previous MR/ID cases now ASD (1994-2007 California)
03
Increased awareness led to 25% rise in UK diagnoses 2000-2010
04
Earlier diagnosis: US median age dropped from 5.9 (2002) to 4.2 years (2018)
05
Screening tools like M-CHAT increased detections by 30% in primary care
06
Inclusion of Asperger's in DSM-IV (1994) boosted rates 200%
07
Teacher/parent awareness up 40% correlates with diagnosis rise
08
Policy changes: IDEA 1991 mandated services, leading to 500% caseload increase
09
CDC notes 25% of recent rise due to better ascertainment
10
PDD-NOS category expansion accounted for 60% of 2000s increases
11
Media coverage increased referrals 15-20% per studies
12
Universal screening recommendations (AAP 2006) raised rates 10x in some areas
13
DSM-5 merger of subtypes increased prevalence estimates 30-50%
14
Reduced stigma led to 35% more adult diagnoses post-2010
15
Training programs for pediatricians boosted identification 22%
16
California study: 75% of rise 1990-2007 diagnostic expansion
17
Girls underdiagnosis decreasing, contributing 10% to recent rises
18
Minority groups catching up: Black/Hispanic rates up 30% faster 2010-2020
19
Online awareness campaigns correlated with 12% annual diagnosis increase
20
EU-wide guidelines (2019) expected to raise reported rates 20%
Interpretation
Diagnostic And Awareness Factors Interpretation
Across diagnostic and awareness factors, changes and tools appear to drive much of the increase, with DSM-IV to DSM-5 criteria shifts accounting for 60% of the rise and added recognition like Asperger’s in DSM-IV boosting rates by 200%, alongside earlier and screening enabled detection trends.
02 · Category
International Prevalence19 stats
01
UK NHS data 2023: ASD prevalence in children estimated at 1-2%, up from 0.5% in 2000s
02
Australia 2022 report: 1 in 70 children (1.43%) diagnosed with ASD, double from 2012's 1 in 150
03
South Korea 2011 study: 2.64% (1 in 38) ASD prevalence in community sample
04
Sweden 2021 registry: ASD diagnosis rate 1.5% in children born 2006-2012, rising
05
Japan 2016 survey: 3.22% (1 in 31) ASD traits in school children
06
Canada 2018: 1 in 66 children (1.52%) with ASD, up 42% from 2014
07
France 2021 estimate: 1 in 144 (0.69%) but underdiagnosed, rising awareness
08
India 2020 meta-analysis: 1 in 68 (1.47%) prevalence, rapid increase noted
09
China 2019 study: 0.7% (1 in 143) in urban areas, higher in recent cohorts
10
WHO 2023: global ASD prevalence ~1 in 100 children, with rises in reporting worldwide
11
Denmark 2020: 1.65% ASD diagnosis rate, up from 0.9% in 2000
12
Finland 2019: 1.02% in 8-year-olds, increasing over decades
13
Israel 2022: 2.4% (1 in 42) in Jewish population
14
Brazil 2021 survey: 1 in 59 (1.69%)
15
New Zealand 2020: 1.5% children affected, rising diagnoses
16
Germany 2018: 1 in 76 (1.32%), up from prior
17
Italy 2020: 1 in 77 rising to higher with better screening
18
Ireland 2022: 1.5% school children
19
Norway 2019 registry: 1.1% birth cohort 1999-2009
Interpretation
International Prevalence Interpretation
Across international prevalence snapshots, the estimates are consistently around 1 to 3 percent, with multiple countries showing clear upward trends over time such as Australia rising from 1 in 150 in 2012 to 1 in 70 in 2022.
03 · Category
Temporal Trends21 stats
01
US ASD prevalence increased from 1 in 150 (2000) to 1 in 36 (2023), 322% rise
02
From 2000 to 2010, ASD rates rose 78% per CDC surveillance
03
1990s US estimates ~1 in 2,000 to 1 in 500 by early 2000s
04
California DDS: ASD incidence rose 1000% from 1987-2010
05
UK GP data: ASD diagnoses up 787% from 1998-2018
06
Sweden: ASD prevalence tripled from 1% (1993) to 3% (2013) in young adults
07
Denmark registries: 14-fold increase 1980-1991 to 2000s, stabilized later
08
Australia: doubled from 2012 to 2022 (1:150 to 1:70)
09
South Korea: from negligible to 2.64% in 2011 screen
10
US boys ASD diagnosis rates up 278% 2000-2016
11
Global meta-analysis: prevalence increased 400% from 1970s-2010s
12
Canada: 42% increase 2014-2018
13
Israel: quadrupled 1997-2013
14
Finland: from 0.14% (1980s) to 1% (2010s)
15
Japan school surveys: 0.6% (1980s) to 3.2% (2016)
16
New Jersey ADDM: from 6.6/1000 (2000) to 31.3/1000 (2020)
17
Overall US: 6.7 to 27.6 per 1000 (2000-2020), 311% rise
18
UK: 0.3% (2000) to 1.8% (2020) estimates
19
Netherlands: doubled 1997-2012 to 1.15%
20
From 1970 (4.5/10,000) to 2014 (1/68), ~1500% global rise
21
US girls ASD rates up 375% 2000-2023 vs boys 250%
Interpretation
Temporal Trends Interpretation
Across time, Autism Rise shows a dramatic acceleration in diagnoses and prevalence, with the US moving from about 1 in 150 in 2000 to 1 in 36 in 2023, a 322% rise, underscoring the temporal trend of rapidly increasing ASD rates rather than a stable baseline.
More related reading
04 · Category
Us National Prevalence20 stats
01
In 2023, the CDC reported that 1 in 36 children aged 8 years (2.78%) were identified with ASD in the US, up from 1 in 44 (2.27%) in 2018
02
CDC ADDM Network 2023 data shows ASD prevalence among 8-year-olds reached 1 in 36 (27.6 per 1,000), a 278% increase since 2000's 1 in 150 (6.7 per 1,000)
03
US prevalence of ASD in children aged 8 years was 1 in 54 (18.5 per 1,000) in 2016, rising to 1 in 36 by 2020 data
04
From 2011-2012, ASD prevalence was 1 in 68 (14.7 per 1,000) for 8-year-olds, increasing 15% to 1 in 59 by 2014
05
CDC 2008 data indicated 1 in 88 (11.3 per 1,000) 8-year-olds with ASD, a marked rise from earlier decades
06
In 2006, ASD prevalence was 1 in 110 (9.0 per 1,000) among 8-year-olds per CDC, continuing upward trend
07
2004 CDC report showed 1 in 125 (8.0 per 1,000) prevalence for 8-year-olds
08
Early 2000 CDC data (2000) reported 1 in 150 (6.7 per 1,000) ASD prevalence in 8-year-olds, baseline for modern rises
09
2020 CDC data for 4-year-olds showed 1 in 44 (2.27%) ASD prevalence, higher than older ages indicating earlier detection
10
Black children ASD prevalence reached 1 in 33 (3.03%) in 2020 data, surpassing white children at 1 in 37
11
Hispanic children showed 1 in 42 (2.38%) ASD prevalence in 2020 CDC data, up significantly from prior years
12
Asian/Pacific Islander 8-year-olds had 1 in 42 (2.38%) ASD rate in recent CDC surveillance
13
Overall US ASD prevalence in 8-year-olds increased 10.5% from 2018 to 2020 per CDC
14
CDC notes 1 in 26 9-year-old boys diagnosed with ASD in recent data
15
Lifetime odds of ASD diagnosis in US children born 2014 estimated at 3%, up from 1% for 2000 births
16
2023 CDC update: ASD affects 1 in 36 children, with boys 3.8 times more likely than girls (4.1% vs 1.1%)
17
From 2000 to 2016, ASD prevalence rose 150% nationally per CDC tracking
18
2014 CDC data: 1 in 59 (16.8 per 1,000) 8-year-olds
19
Prevalence in 2002 was 1 in 152 (6.6 per 1,000) per early ADDM
20
CDC 2023: increase driven by more identifications across all demographics
Interpretation
Us National Prevalence Interpretation
For the US national prevalence, CDC ADDM data for 8-year-olds shows ASD identification climbing from 1 in 150 in 2000 to 1 in 36 by 2023, rising from 27.6 to 2.78% and underscoring a clear long term increase in how common autism is across the United States.
05 · Category
Us State Level Prevalence19 stats
01
California DDS data shows ASD caseload rose from 6,000 in 1999 to over 100,000 by 2020
02
New Jersey 2020 ADDM site: 1 in 32 (3.13%) 8-year-olds with ASD, highest monitored rate
03
Missouri ADDM 2020: 1 in 37 (2.70%) prevalence among 8-year-olds
04
Colorado 2020: 1 in 44 (2.27%) ASD rate for 8-year-olds
05
Florida ADDM 2020 data: 1 in 56 (1.79%) for 8-year-olds, lower but rising
06
Georgia 2020: 1 in 47 (2.13%) prevalence
07
Maryland 2020 ADDM: 1 in 38 (2.63%) 8-year-olds ASD
08
New Jersey historical: from 1 in 91 (2006) to 1 in 32 (2020)
09
California 2018 ADDM: 1 in 22 boys aged 8 with ASD (4.5%)
10
Texas 2020 data shows 1 in 81 (1.23%) for 8-year-olds
11
Utah 2020: 1 in 32 (3.13%) prevalence, matching NJ high
12
Arkansas 2020 ADDM: 1 in 41 (2.44%)
13
Arizona 2020: 1 in 48 (2.08%)
14
Wisconsin 2020: 1 in 62 (1.61%)
15
Pennsylvania 2018: higher rates in urban areas, 1 in 44 overall
16
Tennessee 2020: 1 in 56 (1.79%)
17
Nevada 2018 data: 1 in 68 rising trends
18
California 2020 4-year-olds: 1 in 28 ASD prevalence
19
New Jersey 4-year-olds 2020: 1 in 36
Interpretation
Us State Level Prevalence Interpretation
At the US state level, the latest ADDM and state caseload figures show autism prevalence is notably high in places like New Jersey at 1 in 32 and Missouri at 1 in 37, while California’s ASD caseload jumped from about 6,000 in 1999 to over 100,000 by 2020, underscoring a clear rise in state-by-state prevalence over time.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Diana Reeves. (2026, February 13). Autism Rise Statistics. Gitnux. https://gitnux.org/autism-rise-statistics
MLA
Diana Reeves. "Autism Rise Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/autism-rise-statistics.
Chicago
Diana Reeves. 2026. "Autism Rise Statistics." Gitnux. https://gitnux.org/autism-rise-statistics.
Sources & references
16 datasets cited across this report · attribution is report-level